| Literature DB >> 30584013 |
Raphael F Casseb1, Brunno M de Campos2, Alberto R M Martinez3, Gabriela Castellano4, Marcondes C França Junior5.
Abstract
Sensory-motor integration models have been proposed aiming to explain how the brain uses sensory information to guide and check the planning and execution of movements. Sensory neuronopathy (SN) is a peculiar disease characterized by exclusive, severe and widespread sensory loss. It is a valuable condition to investigate how sensory deafferentation impacts brain organization. We thus recruited patients with clinical and electrophysiological criteria for SN to perform structural and functional MRI analyses. We investigated volumetric changes in gray matter (GM) using anatomical images; the microstructure of WM within segmented regions of interest (ROI), via diffusion images; and brain activation related to a finger tapping task. All significant results were related to the long disease duration subgroup of patients. Structural analysis showed hypertrophy of the caudate nucleus, whereas the diffusion study identified reduction of fractional anisotropy values in ROIs located around the thalamus and the striatum. We also found differences regarding finger-tapping activation in the posterior parietal regions and in the medial areas of the cerebellum. Our results stress the role of the caudate nucleus over the other basal ganglia in the sensory-motor integration models, and suggest an inhibitory function of a recently discovered tract between the thalamus and the striatum. Overall, our findings confirm plasticity in the adult brain and open new avenues to design neurorehabilitation strategies.Entities:
Keywords: Deafferentation; MRI; Plasticity; Sensory neuronopathy; Sensory-motor integration
Mesh:
Year: 2018 PMID: 30584013 PMCID: PMC6411904 DOI: 10.1016/j.nicl.2018.101633
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Fig. 1Study Design. Scheme representing the rationale of the analyses performed and the tools used.
Clinical and demographic data of SN patients
| Total SN ( | Long disease duration SN (n = 19) | Short disease duration SN (n = 8) | |
|---|---|---|---|
| Age (mean ± SD, years) | 51 ± 11 | 54 ± 10 | 42 ± 11 |
| Gender (M/F) | 10/17 | 6/13 | 4/4 |
| Disease duration (mean ± SD, years) | 10.4 ± 8.8 | 14.0 ± 8.1 | 2.6 ± 1.8 |
| SARA (mean ± SD) | 11.5 ± 6.0 | 13.2 ± 6.0 | 7.4 ± 4.1 |
| Pseudoathetosis (%) | 74 | 65 | 100 |
| Disease course (%) (Acute/Subacute/Chronic) | 18/11/70 | 21/5/74 | 13/25/62 |
| Etiology | |||
| Idiopathic | 15/27 | 11/19 | 4/8 |
| Sjögren Syndrome | 6/27 | 4/19 | 2/8 |
| Autoim. Hepatitis | 4/27 | 2/19 | 2/8 |
| HTLV | 1/27 | 1/19 | |
| MGUS | 1/27 | 1/19 | |
Human T-cell lymphotrophic virus.
Monoclonal gammopathy of unknown significance.
Fig. 2Hypertrophic regions in the long disease duration subgroup of sensory neuronopathy (SN) patients. Gray matter volumetric analysis revealed hypertrophy in the left caudate nucleus of long disease duration subgroup compared to controls (FDR-corrected p = 0.012), and a trend towards significance of the right caudate (FDR-corrected p = 0.054). Green and red indicate the right and left caudate nuclei, respectively.
Fig. 3White matter abnormalities in the long disease duration subgroup of sensory neuronopathy (SN) patients. Tracts with reduced mean FA values (p < 0.05 corrected for false discovery rate) in long disease duration subgroup of SN patients compared to controls. Numbers next to the coronal slices represents y coordinates (mm) in the MNI space. Even though the analysis was performed in the native space, the figure above was normalized to the standard MNI152 space for illustration purposes.
Fig. 4Scatter plots showing the correlations between FA values and SARA scores. (A) Left fornix (LF), (B) body of corpus callosum (BCC), and (C) right posterior thalamic radiation (RPTR). Only regions of interest that showed significant association are depicted.
Fig. 5Activation maps related to the finger-tapping task. Greater activation during eyes-open compared to eyes-closed condition is shown for (A) controls and (B) long disease duration subgroup of SN patients.